Proton Therapy available to Prague, Asia and Pacific Rim including Singapore, Australia, New Zealand, Thailand and Malaysia

NCC Proton Center Meeting

Only 5% of 130,000 U.S. Patients alone will have access to Particle Therapy now While Europe and Asia face an even greater underserved demand!  

Today, cancer is the second highest cause of death in developed countries. Its treatment still presents a real challenge. At NCC Proton Center in Seoul, we consider each day as a new challenge in the ongoing struggle to find ways of fighting this disease.

Approximately 45% of all patients can now be cured through the role of surgery, radiotherapy and/or chemotherapy. Nearly 50% of all Patients receive radiation therapy during the course of their treatment. Most radiation therapy is delivered with beams external to the body, of which ProtonParticle Therapy is the most precise.

Of the 130,000 new patients eligible to undergo Particle Therapy in the U.S alone every year, only 5% of them will have the opportunity to actually benefit from this new technology.

As anyone familiar with external beam radiotherapy knows, an unfortunate The consequence is the unavoidable “spilling” of radiation into tissue proximal, distal, and adjacent to the tumor.

The ever-expanding list of indications suitable for Particle Therapy, given its greater precision control over dose deposition and potential to complement and enhance other forms of therapy, is causing more health care providers to seek out this treatment option for their patients and community. Start the treatment process here.